
Arthroplasty
Comparable clinical outcomes with CPCS stem and traditional Exeter femoral stem
This report has been verified
by one or more authors of the
original publication.
J Bone Joint Surg Br. 2010 Jul;92(7):935-40.
34 patients (60 to 85 years of age) with osteoarthritis of the hip, scheduled for primary cemented Total Hip Replacement (THR), were randomized to receive CPCS, collarless femoral component, or Exeter collared femoral stem. 2 years after THR, the CPCS stem and the Exeter Universal femoral stem were observed to have similar clinical outcomes. The migration was slightly less in the group with CPCS Stem.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.